Scribd Logo
Carica

Benvenuto in Scribd!

  • SWOT Analysis of Pharmaceutical Industry Bangladesh HKH Ygg Iyhuih Iyhuihuih Uyuhykhj

    Caricato da

    myhellonearth
    231 visualizzazioni2 pagine
    New entrant strategy: if the new comer is a large-investment one then it is likely to sell almost the same products launched by the market leaders with some different new products. This type of companies establish their factories with a very standard quality keeping export as an important option in their mind.( according to Square and ACI) If the new comer is a medium or small size one, then it is more likely to serve its own niche which is commonly a semi rural or semi urban market. ( according to General pharma, Radiant pharma and ADRUC pharma) yugyujh yuhguh gygyg New entrant strategy: if the new comer is a large-investment one then it is likely to sell almost the same products launched by the market leaders with some different new products. This type of companies establish their factories with a very standard quality keeping export as an important option in their mind.( according to Square and ACI) If the new comer is a medium or small size one, then it is more likely to serve its own niche which is commonly a semi rural or semi urban market. ( according to General pharma, Radiant pharma and ADRUC pharma)New entrant strategy: if the new comer is a large-investment one then it is likely to sell almost the same products launched by the market leaders with some different new products. This type of companies establish their factories with a very standard quality keeping export as an important option in their mind.( according to Square and ACI) If the new comer is a medium or small size one, then it is more likely to serve its own niche which is commonly a semi rural or semi urban market. ( according to General pharma, Radiant pharma and ADRUC pharma)

    Titolo originale

    SWOT Analysis of Pharmaceutical Industry Bangladesh hkh ygg iyhuih iyhuihuih uyuhykhj

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Formati disponibili

    DOCX, PDF, TXT o leggi online da Scribd

    Hai trovato utile questo documento?

    Questo contenuto è inappropriato?

    Segnala questo documento
    New entrant strategy: if the new comer is a large-investment one then it is likely to sell almost the same products launched by the market leaders with some different new products. This type of companies establish their factories with a very standard quality keeping export as an important option in their mind.( according to Square and ACI) If the new comer is a medium or small size one, then it is more likely to serve its own niche which is commonly a semi rural or semi urban market. ( according to General pharma, Radiant pharma and ADRUC pharma) yugyujh yuhguh gygyg New entrant strategy: if the new comer is a large-investment one then it is likely to sell almost the same products launched by the market leaders with some different new products. This type of companies establish their factories with a very standard quality keeping export as an important option in their mind.( according to Square and ACI) If the new comer is a medium or small size one, then it is more likely to serve its own niche which is commonly a semi rural or semi urban market. ( according to General pharma, Radiant pharma and ADRUC pharma)New entrant strategy: if the new comer is a large-investment one then it is likely to sell almost the same products launched by the market leaders with some different new products. This type of companies establish their factories with a very standard quality keeping export as an important option in their mind.( according to Square and ACI) If the new comer is a medium or small size one, then it is more likely to serve its own niche which is commonly a semi rural or semi urban market. ( according to General pharma, Radiant pharma and ADRUC pharma)

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Scarica in formato DOCX, PDF, TXT o leggi online su Scribd
    Segnala contenuti inappropriati
    231 visualizzazioni2 pagine

    SWOT Analysis of Pharmaceutical Industry Bangladesh HKH Ygg Iyhuih Iyhuihuih Uyuhykhj

    Caricato da

    myhellonearth
    New entrant strategy: if the new comer is a large-investment one then it is likely to sell almost the same products launched by the market leaders with some different new products. This type of companies establish their factories with a very standard quality keeping export as an important option in their mind.( according to Square and ACI) If the new comer is a medium or small size one, then it is more likely to serve its own niche which is commonly a semi rural or semi urban market. ( according to General pharma, Radiant pharma and ADRUC pharma) yugyujh yuhguh gygyg New entrant strategy: if the new comer is a large-investment one then it is likely to sell almost the same products launched by the market leaders with some different new products. This type of companies establish their factories with a very standard quality keeping export as an important option in their mind.( according to Square and ACI) If the new comer is a medium or small size one, then it is more likely to serve its own niche which is commonly a semi rural or semi urban market. ( according to General pharma, Radiant pharma and ADRUC pharma)New entrant strategy: if the new comer is a large-investment one then it is likely to sell almost the same products launched by the market leaders with some different new products. This type of companies establish their factories with a very standard quality keeping export as an important option in their mind.( according to Square and ACI) If the new comer is a medium or small size one, then it is more likely to serve its own niche which is commonly a semi rural or semi urban market. ( according to General pharma, Radiant pharma and ADRUC pharma)

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Scarica in formato DOCX, PDF, TXT o leggi online su Scribd
    Segnala contenuti inappropriati
    di 2

    SWOT analysis of Bangladesh (pharmaceutical industry) Strength Weakness Opportunities Threat Cheaper medicines from India and China

    Developing countries like Brazil is using compulsory licensing India has amended 1970's Patent Act as favorable as possible 97%of the medicines sold in India are offpatented Bangladesh will face tough competition after 2016

    NDL favoring local Pharmaceutical Insufficient Developing countries are not industries production of raw allowed to produce patented materials drugs after January 2005 Sufficient local production Absence of No obligation to provide bioequivalence testing patent protection until 2016 and clinical trial under TRIPs facilities Manufacture hi-tech lyophilized Lack of qualified Advantages of compulsory Anticancer drugs, Hormones, Anti- scientist to carry out licensing retroviral CARV), Vaccines etc. Quality medicines Reverse engineering to produce API Parallel imports and Bolar provision contract manufacturing opportunities with multinational companies

    Wide range of formulation

    No connection between academic institutions and professional organization Nearly self sufficiency in quality API Poor knowledge of TRIPs and other related issues, Sufficient production capacity for contract manufacturing Exporting basic chemicals to many countries

    Joint venture and toll manufacturing

    Goods damage, theft Highly educated and skill and negative hassles human resources in the ports, High freight cost, Inferior country image.

    Developing some other widely Government Abundant and competitive used APIs restrictions: -sample labor force and promotional materials - imported raw materials, process of duty drawback is lengthy and cumbersome, Absence of Government incentives: Cash incentives and tax exemption.( RMG sector is enjoying 50% exemption and India is providing 20% cash incentive to Pharma exporters -Export credit period should be extended.

    Potrebbero piacerti anche